The 12 references in paper L. Ugay G., V. Nevzorova A., E. Kochetkova A., Yu. Maystrovskaya V., A. Shmykov V., Л. Угай Г., В. Невзорова А., Е. Кочеткова А., Ю. Майстровская В., А. Шмыков В. (2016) “Состояние адипокиновой регуляции и эндотелиальной дисфункции у пациентов с хронической обструктивной болезнью легких c различной минеральной плотностью костной ткани // Аdipokine regulation and endothelial dysfunction in patients with chronic obstructive pulmonary disease and different bone mineral density” / spz:neicon:pulmonology:y:2015:i:5:p:517-523

1
Global Initiative for Chronic Obstructive Lung Disease (updated 2013). http://www.goldcopd.org/uploads/users/ files/GOLD_Reports_2013_Feb20.pdf
(check this in PDF content)
2
Кочеткова Е.А., Угай Л.Г., Mайстровская Ю.В. и др. Новые механизмы формирования остеопороза при терминальной легочной патологии. Тихоокеанский ме' дицинский журнал.2013; 4: 72–75. / Kochetkova E.A., Ugay L.G., Maystrovskaya Yu.V. et al. Novel pathogenic mechanisms of osteoporosis in patients with an advanced pulmonary disease. Tikhookeanskiy meditsinskiy zhurnal. 2013; 4: 72–75 (in Russian).
(check this in PDF content)
3
Uzum A.K., Aydin M.M., Tutuncu Y.I. et al. Serum grelin and adipinectin are increased but serum leptin level is unchanged in low weight chronic obstructive pulmonary disease patients. Eur. J. Intern. Med.2014; 25: 364–369.
(check this in PDF content)
4
Sumino H., Ichikawa S., Kasama S. et al. Relationship between brachial arterial endothelial function and lumbar spine bone mineral density in postmenopausal women. Circ. J. 2007; 71: 1555–1559.
(check this in PDF content)
5
Alangiakrishman K., Juby A., Hanley D. et al. Role of vascular factors in osteoporosis.J. Gerontol. Med. Sci.2003; 58: 362–366.
(check this in PDF content)
6
Nakanishi K., Takeda Y., Tetsumoto S. et al. Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice. Implications for therapy. Am. J. Respir. Crit. Care Med. 2011; 183: 1164–1175.
(check this in PDF content)
7
Graat-Verboom L., Wouters E.F., Smeenk F.W. et al. Current status of research on osteoporosis in COPD: a systematic review. Eur. Respir. J. 2009; 34: 209–218.
(check this in PDF content)
8
Lehouck A., Bonen S., Decramer M., Janssens W. COPD, bone metabolism and osteoporosis. Chest. 2011; 139: 648–657.
(check this in PDF content)
9
Watanabe R., Tanaka T., Aita K. et al. Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function. J. Bone Miner. Metab.2015; 33 (4): 392–400.
(check this in PDF content)
10
Graat-Verboom L., van den Borne B.E., Smeek F.W. et al. Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. J. Bone Miner. Res. 2011; 26: 561–568.
(check this in PDF content)
11
Dennison E.M., Dhanwal D.K., Shahech S.O. et al. Is lung function associated with bone mineral density? Results from the Hertfoldshire Cohort Study. Arch. Osteoporos.2013; 8: 115–127.
(check this in PDF content)
12
Julia C., Czernichow S., Charnaux N. et al. Relationships between adipokines, biomarkers of endothelial function and inflammation and risk of type 2 diabetes.Diabet. Res. Clin. Pract.2014; 105 (2): 231–238. 31. Vondracek S.F., Voelkel N.F., McDermott M.T., Valdez C.
(check this in PDF content)